Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2011, Article ID 746532, 12 pages
http://dx.doi.org/10.1155/2011/746532
Research Article

Systemically Administered Ligands of Toll-Like Receptor 2, -4, and -9 Induce Distinct Inflammatory Responses in the Murine Lung

1Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Sigmund-Freud-Straße 25, 53105 Bonn, Germany
2Institute of Physiology II, University of Bonn, Nussallee 11, 53115 Bonn, Germany
3Department for Pneumology, Evangelische Lungenklinik, Berlin, Lindenberger Weg 27, Haus 205, 13125 Berlin, Germany

Received 9 September 2010; Revised 12 January 2011; Accepted 23 January 2011

Academic Editor: Tânia Silvia Fröde

Copyright © 2011 H. Ehrentraut et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. C. Angus, C. A. P. Pereira, and E. Silva, “Epidemiology of severe sepsis around the world,” Endocrine, Metabolic and Immune Disorders, vol. 6, no. 2, pp. 207–212, 2006. View at Google Scholar · View at Scopus
  2. K. Kuwano, “Epithelial cell apoptosis and lung remodeling,” Cellular & Molecular Immunology, vol. 4, no. 6, pp. 419–429, 2007. View at Google Scholar · View at Scopus
  3. A. P. Wheeler and G. R. Bernard, “Treating patients with severe sepsis,” The New England Journal of Medicine, vol. 340, no. 3, pp. 207–214, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. G. D. Rubenfeld and M. S. Herridge, “Epidemiology and outcomes of acute lung injury,” Chest, vol. 131, no. 2, pp. 554–562, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Poltorak, X. He, I. Smirnova et al., “Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in TLR4 gene,” Science, vol. 282, no. 5396, pp. 2085–2088, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. O. Takeuchi, K. Hoshino, T. Kawai et al., “Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components,” Immunity, vol. 11, no. 4, pp. 443–451, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Hemmi, O. Takeuchi, T. Kawai et al., “A Toll-like receptor recognizes bacterial DNA,” Nature, vol. 408, no. 6813, pp. 740–745, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Krieg, A. K. Yi, S. Matson et al., “CpG motifs in bacterial DNA trigger direct B-cell activation,” Nature, vol. 374, no. 6522, pp. 546–549, 1995. View at Google Scholar · View at Scopus
  9. M. Nishimura and S. Naito, “Tissue-specific mRNA expression profiles of human toll-like receptors and related genes,” Biological and Pharmaceutical Bulletin, vol. 28, no. 5, pp. 886–892, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. N. W. J. Schröder and M. Arditi, “IEIIS Meeting minireview: the role of innate immunity in the pathogenesis of asthma: evidence for the involvement of Toll-like receptor signaling,” Journal of Endotoxin Research, vol. 13, no. 5, pp. 305–312, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. D. Pawar, A. Ramanjaneyulu, O. P. Kulkarni, M. Lech, S. Segerer, and H. J. Anders, “Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus,” Journal of the American Society of Nephrology, vol. 18, no. 6, pp. 1721–1731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Baumgarten, P. Knuefermann, H. Wrigge et al., “Role of toll-like receptor 4 for the pathogenesis of acute lung injury in gram-negative sepsis,” European Journal of Anaesthesiology, vol. 23, no. 12, pp. 1041–1048, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Li, Z. Ma, Z. L. Tang, T. Stevens, B. Pitt, and S. Li, “CpG DNA-mediated immune response in pulmonary endothelial cells,” American Journal of Physiology, vol. 287, no. 3, pp. L552–L558, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Knuefermann, G. Baumgarten, A. Koch et al., “CpG oligonucleotide activates Toll-like receptor 9 and causes lung inflammation in vivo,” Respiratory Research, vol. 8, article 72, 2007. View at Google Scholar · View at Scopus
  15. K. J. Ishii, S. Uematsu, and S. Akira, “'Toll' gates for future immunotherapy,” Current Pharmaceutical Design, vol. 12, no. 32, pp. 4135–4142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. J. J. Hoogerwerf, A. F. De Vos, P. Bresser et al., “Lung inflammation induced by lipoteichoic acid or lipopolysaccharide in humans,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 1, pp. 34–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Morath, A. Geyer, and T. Hartung, “Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus,” Journal of Experimental Medicine, vol. 193, no. 3, pp. 393–397, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Baumgarten, P. Knuefermann, G. Schuhmacher et al., “Toll-like receptor 4, nitric oxide, and myocardial depression in endotoxemia,” Shock, vol. 25, no. 1, pp. 43–49, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Knuefermann, M. Schwederski, M. Velten et al., “Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9,” Cardiovascular Research, vol. 78, no. 1, pp. 26–35, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. C. Alves-Filho, A. Freitas, F. O. Souto et al., “Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 10, pp. 4018–4023, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, “Measurement of tumor necrosis factor,” in Current Protocols in Immunology, R. Coico, Ed., John Wiley & Sons, New York, NY, USA, 1994. View at Google Scholar
  22. P. Knuefermann, S. Nemoto, A. Misra et al., “CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction,” Circulation, vol. 106, no. 20, pp. 2608–2615, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Chomczynski and N. Sacchi, “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction,” Analytical Biochemistry, vol. 162, no. 1, pp. 156–159, 1987. View at Google Scholar · View at Scopus
  24. M. Bhatia and S. Moochhala, “Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome,” Journal of Pathology, vol. 202, no. 2, pp. 145–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. I. Albrecht, T. Tapmeier, S. Zimmermann, M. Frey, K. Heeg, and A. Dalpke, “Toll-like receptors differentially induce nucleosome remodelling at the IL-12p40 promoter,” EMBO Reports, vol. 5, no. 2, pp. 172–177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Saito, T. Yamamoto, T. Kazawa, H. Gejyo, and M. Naito, “Expression of toll-like receptor 2 and 4 in lipopolysaccharide-induced lung injury in mouse,” Cell and Tissue Research, vol. 321, no. 1, pp. 75–88, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. K. Mayer, M. Muehmer, J. Mages et al., “Differential recognition of TLR-dependent microbial ligands in human bronchial epithelial cells,” Journal of Immunology, vol. 178, no. 5, pp. 3134–3142, 2007. View at Google Scholar · View at Scopus
  28. J. C. Leemans, M. Heikens, K. P. M. Van Kessel, S. Florquin, and T. Van der Poll, “Lipoteichoic acid and peptidoglycan from Staphylococcus aureus synergistically induce neutrophil influx into the lungs of mice,” Clinical and Diagnostic Laboratory Immunology, vol. 10, no. 5, pp. 950–953, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. D. van Zoelen, A. F. De Vos, G. J. Larosa, C. Draing, S. Von Aulock, and T. van der Poll, “Intrapulmonary delivery of ethyl pyruvate attenuates lipopolysaccharide- and lipoteichoic acid-induced lung inflammation in vivo,” Shock, vol. 28, no. 5, pp. 570–575, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Sabroe, S. K. Dower, and M. K. B. Whyte, “The role of Toll-like receptors in the regulation of neutrophil migration, activation, and apoptosis,” Clinical Infectious Diseases, vol. 41, no. 7, supplement, pp. S421–S426, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Reutershan, A. Basit, E. V. Galkina, and K. Ley, “Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury,” American Journal of Physiology, vol. 289, no. 5, pp. L807–L815, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. D. A. Schwartz, T. J. Quinn, P. S. Thorne, S. Sayeed, AE. K. Yi, and A. M. Krieg, “CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract,” Journal of Clinical Investigation, vol. 100, no. 1, pp. 68–73, 1997. View at Google Scholar · View at Scopus
  33. S. Yamamoto, W.-S. Tin-Tin, S. Ahmed, T. Kobayashi, and H. Fujimaki, “Effect of ultrafine carbon black particles on lipoteichoic acid-induced early pulmonary inflammation in BALB/c mice,” Toxicology and Applied Pharmacology, vol. 213, no. 3, pp. 256–266, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Corbel, E. Boichot, and V. Lagente, “Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury,” Brazilian Journal of Medical and Biological Research, vol. 33, no. 7, pp. 749–754, 2000. View at Google Scholar · View at Scopus
  35. D. F. Gibbs, T. P. Shanley, R. L. Warner, H. S. Murphy, J. Varani, and K. J. Johnson, “Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury: evidence for alveolar macrophage as source of proteinases,” American Journal of Respiratory Cell and Molecular Biology, vol. 20, no. 6, pp. 1145–1154, 1999. View at Google Scholar · View at Scopus
  36. U. Hoffmann, T. Bertsch, E. Dvortsak et al., “Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis,” Scandinavian Journal of Infectious Diseases, vol. 38, no. 10, pp. 867–872, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Lanchou, M. Corbel, M. Tanguy et al., “Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients,” Critical Care Medicine, vol. 31, no. 2, pp. 536–542, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. K. M. Beeh, J. Beier, O. Kornmann, and R. Buhl, “Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects,” Respiratory Medicine, vol. 97, no. 6, pp. 634–639, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. I. I. Ekekezie, D. W. Thibeault, S. D. Simon et al., “Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease,” Pediatrics, vol. 113, no. 6, pp. 1709–1714, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. E. L. Martin, T. A. Sheikh, K. J. Leco, J. F. Lewis, and R. A. W. Veldhuizen, “Contribution of alveolar macrophages to the response of the TIMP-3 null lung during a septic insult,” American Journal of Physiology, vol. 293, no. 3, pp. L779–L789, 2007. View at Publisher · View at Google Scholar · View at Scopus